Roche (OTCMKTS:RHHBY) Sets New 52-Week High – Time to Buy?

Roche Holding AG (OTCMKTS:RHHBY)’s share price hit a new 52-week high during mid-day trading on Tuesday . The stock traded as high as $60.49 and last traded at $60.4420, with a volume of 243373 shares traded. The stock had previously closed at $59.97.

Wall Street Analyst Weigh In

A number of equities analysts have issued reports on RHHBY shares. Morgan Stanley reaffirmed an “underweight” rating on shares of Roche in a research report on Wednesday, February 4th. TD Cowen reaffirmed a “hold” rating on shares of Roche in a research note on Tuesday, February 10th. Citigroup initiated coverage on shares of Roche in a report on Tuesday, January 27th. They set a “buy” rating on the stock. Jefferies Financial Group downgraded shares of Roche from a “hold” rating to a “moderate sell” rating in a report on Monday, October 27th. Finally, JPMorgan Chase & Co. raised shares of Roche from an “underweight” rating to a “neutral” rating in a research note on Monday, December 8th. Three analysts have rated the stock with a Buy rating, five have assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the stock has an average rating of “Hold” and an average target price of $57.00.

Roche Trading Up 0.9%

The firm’s 50 day moving average is $54.75 and its 200 day moving average is $47.49. The company has a quick ratio of 1.12, a current ratio of 1.38 and a debt-to-equity ratio of 0.72.

Hedge Funds Weigh In On Roche

A number of institutional investors and hedge funds have recently modified their holdings of the stock. Verity Asset Management Inc. grew its holdings in Roche by 12.5% during the 2nd quarter. Verity Asset Management Inc. now owns 9,092 shares of the company’s stock valued at $371,000 after purchasing an additional 1,008 shares during the last quarter. First Horizon Advisors Inc. boosted its holdings in Roche by 81.2% during the 2nd quarter. First Horizon Advisors Inc. now owns 1,843 shares of the company’s stock valued at $75,000 after acquiring an additional 826 shares during the period. Everett Harris & Co. CA lifted its position in shares of Roche by 3.5% during the second quarter. Everett Harris & Co. CA now owns 11,190 shares of the company’s stock worth $456,000 after purchasing an additional 381 shares during the last quarter. FineMark National Bank & Trust purchased a new position in Roche in the 2nd quarter worth about $210,000. Finally, Rhumbline Advisers increased its position in shares of Roche by 1.1% during the second quarter. Rhumbline Advisers now owns 108,480 shares of the company’s stock worth $4,422,000 after acquiring an additional 1,228 shares during the period.

Roche Company Profile

Roche Holding AG is a Swiss multinational healthcare company headquartered in Basel, founded in 1896 by Fritz Hoffmann‑La Roche. The company operates primarily through two complementary divisions — Pharmaceuticals and Diagnostics — and is known for integrating drug development with diagnostic capabilities to advance personalized healthcare. In the United States and other international markets, shares trade as American Depositary Receipts under the ticker RHHBY (OTCMKTS:RHHBY).

In pharmaceuticals, Roche focuses on developing and commercializing prescription medicines across therapeutic areas including oncology, immunology, infectious diseases and neuroscience, with a notable emphasis on targeted biologics and personalized therapies.